1. Home
  2. OPRA vs PHAR Comparison

OPRA vs PHAR Comparison

Compare OPRA & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Opera Limited

OPRA

Opera Limited

HOLD

Current Price

$11.75

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$16.10

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPRA
PHAR
Founded
1996
1988
Country
Norway
Netherlands
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
OPRA
PHAR
Price
$11.75
$16.10
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$23.50
$38.00
AVG Volume (30 Days)
829.2K
36.6K
Earning Date
02-26-2026
03-12-2026
Dividend Yield
6.79%
N/A
EPS Growth
N/A
N/A
EPS
0.90
0.00
Revenue
$583,449,000.00
$362,274,000.00
Revenue This Year
$27.78
$25.19
Revenue Next Year
$14.63
$4.47
P/E Ratio
$13.12
$2,960.75
Revenue Growth
30.29
26.78
52 Week Low
$11.71
$7.50
52 Week High
$22.50
$21.34

Technical Indicators

Market Signals
Indicator
OPRA
PHAR
Relative Strength Index (RSI) 36.40 37.92
Support Level $12.41 $16.30
Resistance Level $14.87 $18.03
Average True Range (ATR) 0.69 0.76
MACD -0.15 -0.45
Stochastic Oscillator 1.58 3.15

Price Performance

Historical Comparison
OPRA
PHAR

About OPRA Opera Limited

Opera Ltd is a world-wide internet brand with a large, engaged, and growing base. It offers users products and services that include a variety of PC and mobile browsers, Opera Gaming portals and development tools, Opera News content recommendation products, and a number of e-commerce products and services. Its browser's features include tabbed browsing, data savings, PC/mobile sync, and numerous features focused on privacy and security, including ad blocking and a built-in VPN. Its browser products include Opera Mini, Opera Browser for Android and iOS, Opera for Computers, Opera GX and Opera GX Mobile, separate browsers tailored for gamers. Geographically, the company generates maximum revenue from the United States, followed by Singapore, Nigeria, Russia, and other locations.

About PHAR Pharming Group N.V.

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

Share on Social Networks: